| | | 65052 | | 30.07.2014 | | MSD Merck Sharp & Dohme AG | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Janumet XR 50 mg/500 mg | Filmtabletten | Filmtabletten (Metformin Hydrochlorid 500 mg, Sitagliptin Phosphat Monohydrat 64.25 mg) | A10BD07 | PI | | 02 | Janumet XR 50 mg/1000 mg | Filmtabletten | Filmtabletten (Metformin Hydrochlorid 1000 mg, Sitagliptin Phosphat Monohydrat 64.25 mg) | A10BD07 | PI | | 03 | Janumet XR 100 mg/1000 mg | Filmtabletten | Filmtabletten (Metformin Hydrochlorid 1000 mg, Sitagliptin Phosphat Monohydrat 128.5 mg) | A10BD07 | PI |
|
|
